Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,549 | 303 | 93.4% |
| Education | $392.46 | 24 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,675 | 85 | $0 (2024) |
| AbbVie Inc. | $825.21 | 37 | $0 (2023) |
| Astellas Pharma US Inc | $476.97 | 26 | $0 (2024) |
| Duchesnay USA Incorporated | $313.03 | 15 | $0 (2019) |
| Bayer Healthcare Pharmaceuticals Inc. | $234.72 | 15 | $0 (2023) |
| PFIZER INC. | $227.51 | 20 | $0 (2024) |
| TherapeuticsMD, Inc. | $158.47 | 9 | $0 (2022) |
| AMAG Pharmaceuticals, Inc. | $152.01 | 12 | $0 (2019) |
| Organon Llc | $122.79 | 7 | $0 (2024) |
| Orexigen Therapeutics, Inc. | $120.46 | 8 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $564.41 | 22 | Novo Nordisk Inc ($312.43) |
| 2023 | $478.84 | 21 | Novo Nordisk Inc ($100.14) |
| 2022 | $906.14 | 50 | Novo Nordisk Inc ($328.11) |
| 2021 | $521.55 | 27 | Novo Nordisk Inc ($237.84) |
| 2020 | $308.20 | 18 | Novo Nordisk Inc ($215.93) |
| 2019 | $1,431 | 85 | AbbVie, Inc. ($287.00) |
| 2018 | $781.18 | 45 | Novo Nordisk Inc ($143.65) |
| 2017 | $950.66 | 59 | Novo Nordisk Inc ($169.85) |
All Payment Transactions
327 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | MILLICENT US INC | — | Education | In-kind items and services | $13.35 | General |
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: ETONOGESTREL | ||||||
| 11/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Obesity | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Obesity | ||||||
| 09/09/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Obesity | ||||||
| 08/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Obesity | ||||||
| 08/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Obesity | ||||||
| 08/13/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: VACCINES | ||||||
| 08/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $3.34 | General |
| Category: Obesity | ||||||
| 07/16/2024 | Biogen, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: Neurology | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $108.79 | General |
| Category: Obesity | ||||||
| 06/11/2024 | Channel Medsystems, Inc. | — | Food and Beverage | Cash or cash equivalent | $5.39 | General |
| 06/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Obesity | ||||||
| 05/15/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: CONTRACEPTIVE | ||||||
| 05/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Obesity | ||||||
| 04/18/2024 | Medtronic, Inc. | PLASMABLADE(TM) (Device) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: Advanced Energy Cutting Device | ||||||
| 03/21/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 03/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: Obesity | ||||||
| 03/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Obesity | ||||||
| 01/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Obesity | ||||||
| 12/07/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: ETONOGESTREL | ||||||
| 10/18/2023 | AbbVie Inc. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: WOMENS HEALTH | ||||||
| 09/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Womens Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 548 | 553 | $87,347 | $26,050 |
| 2022 | 10 | 661 | 672 | $93,033 | $30,676 |
| 2021 | 10 | 622 | 627 | $79,925 | $27,616 |
| 2020 | 9 | 606 | 610 | $78,408 | $27,091 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 86 | 86 | $29,505 | $9,901 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 109 | $14,610 | $6,018 | 41.2% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 86 | 86 | $13,040 | $4,192 | 32.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 41 | 41 | $15,530 | $1,436 | 9.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 29 | 29 | $2,060 | $1,166 | 56.6% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2023 | 13 | 13 | $7,280 | $1,115 | 15.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 29 | 29 | $1,690 | $1,078 | 63.8% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 42 | 42 | $2,100 | $655.20 | 31.2% |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | Office | 2023 | 14 | 14 | $700.00 | $247.66 | 35.4% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 102 | 104 | $832.00 | $238.96 | 28.7% |
| 77067 | Screening mammography | Office | 2022 | 95 | 95 | $29,925 | $10,801 | 36.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 116 | $12,760 | $6,526 | 51.1% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 95 | 95 | $14,250 | $4,561 | 32.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 52 | 52 | $3,380 | $2,078 | 61.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 51 | 51 | $2,550 | $1,887 | 74.0% |
| 76641 | Complete ultrasound scan of 1 breast | Office | 2022 | 16 | 21 | $8,400 | $1,693 | 20.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 44 | 44 | $16,500 | $1,394 | 8.4% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2022 | 59 | 59 | $2,950 | $910.24 | 30.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 18 | $1,350 | $544.95 | 40.4% |
| 85018 | Blood count, hemoglobin | Office | 2022 | 119 | 121 | $968.00 | $280.33 | 29.0% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 87 | 87 | $27,160 | $10,368 | 38.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 112 | 113 | $12,430 | $6,421 | 51.7% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 87 | 87 | $13,050 | $4,427 | 33.9% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 47 | 47 | $17,370 | $1,659 | 9.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 33 | 33 | $2,145 | $1,343 | 62.6% |
About Dr. Gregory Cook, MD
Dr. Gregory Cook, MD is a Obstetrics & Gynecology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992719454.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Cook, MD has received a total of $5,942 in payments from pharmaceutical and medical device companies, with $564.41 received in 2024. These payments were reported across 327 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($5,549).
As a Medicare-enrolled provider, Cook has provided services to 2,437 Medicare beneficiaries, totaling 2,462 services with total Medicare billing of $111,434. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Augusta, GA
- Active Since 07/28/2006
- Last Updated 11/20/2012
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1992719454
Products in Payments
- Saxenda (Drug) $1,136
- Wegovy (Drug) $489.05
- Orilissa (Drug) $287.00
- Osphena (Drug) $264.16
- LO LOESTRIN FE (Drug) $246.77
- CONTRAVE (Drug) $240.43
- PREMARIN (Drug) $163.58
- Myrbetriq (Drug) $161.78
- Kyleena (Drug) $153.22
- ORILISSA (Drug) $151.93
- NEXPLANON (Drug) $135.39
- INTRAROSA (Drug) $126.19
- MYRBETRIQ (Drug) $116.89
- SLYND (Drug) $110.95
- IMVEXXY (Drug) $107.26
- Lupron (Drug) $105.57
- RS Harmony Test Related Products (Device) $89.27
- Mirena (Drug) $81.50
- OVA1 (Device) $79.92
- MAGNETOM Aera (Device) $77.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Augusta
Dr. Murray Freedman, Md, MD
Obstetrics & Gynecology — Payments: $93,805
Michael Rausch, M.d, M.D
Obstetrics & Gynecology — Payments: $89,995
Dr. C Chance, Md, MD
Obstetrics & Gynecology — Payments: $12,152
Dr. Hatim Lukman, Md, MD
Obstetrics & Gynecology — Payments: $8,395
Dr. Donald Burns, Md, MD
Obstetrics & Gynecology — Payments: $7,924
Dr. William Barfield, Md, MD
Obstetrics & Gynecology — Payments: $6,830